Trinity Biotech (TRIB) Invested Capital (2015 - 2025)

Trinity Biotech (TRIB) has reported Invested Capital for 11 consecutive years, with $13.4 million the latest figure, recorded in Q4 2025.

• Quarterly Invested Capital rose 5.22% year-over-year to $13.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $109.8 million (up 39.79% YoY) and the FY2025 annual result came in at $13.4 million, up 5.22% from the prior year.
• Invested Capital slipped to $13.4 million in Q4 2025 per TRIB's latest filing, from $83.6 million in the prior quarter.
• Over the last five years, Invested Capital for TRIB reached as high as $224.8 million in Q4 2021 and fell as low as -$210000.0 in Q2 2022.
• A 5-year average of $72.5 million and a median of $60.6 million in 2023 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2024 — Invested Capital sank 76.96% — and 2025, when it increased 27.1%.
• Year by year, Invested Capital stood at $224.8 million in 2021, then sank by 44.7% to $124.3 million in 2022, then tumbled by 55.45% to $55.4 million in 2023, then plunged by 76.96% to $12.8 million in 2024, then rose by 5.22% to $13.4 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $13.4 million, $83.6 million, and $12.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.